These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9081202)

  • 1. Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma.
    Teoh G; Anderson KC
    Hematol Oncol Clin North Am; 1997 Feb; 11(1):27-42. PubMed ID: 9081202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interdependence between cytokines and cell adhesion molecules to induce interleukin-6 production by stromal cells in myeloma.
    Thomas X; Anglaret B; Magaud JP; Epstein J; Archimbaud E
    Leuk Lymphoma; 1998 Dec; 32(1-2):107-19. PubMed ID: 10037006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion of multiple myeloma cells to the bone marrow microenvironment: implications for future therapeutic strategies.
    Vidriales MB; Anderson KC
    Mol Med Today; 1996 Oct; 2(10):425-31. PubMed ID: 8897437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion molecules--The lifelines of multiple myeloma cells.
    Katz BZ
    Semin Cancer Biol; 2010 Jun; 20(3):186-95. PubMed ID: 20416379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of adhesion molecules in malignant plasma cells in multiple myeloma: comparison with normal plasma cells and functional significance.
    Helfrich MH; Livingston E; Franklin IM; Soutar RL
    Blood Rev; 1997 Mar; 11(1):28-38. PubMed ID: 9218104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of adhesion molecules in multiple myeloma.
    Cook G; Dumbar M; Franklin IM
    Acta Haematol; 1997; 97(1-2):81-9. PubMed ID: 8980613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of adhesion molecules in the biology of multiple myeloma.
    Van Riet I; Van Camp B
    Leuk Lymphoma; 1993 Apr; 9(6):441-52. PubMed ID: 8339050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines.
    Kim I; Uchiyama H; Chauhan D; Anderson KC
    Br J Haematol; 1994 Jul; 87(3):483-93. PubMed ID: 7993788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of adhesion molecules as a therapeutic strategy in multiple myeloma.
    Neri P; Bahlis NJ
    Curr Cancer Drug Targets; 2012 Sep; 12(7):776-96. PubMed ID: 22671924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of adhesion molecules in multiple myeloma.
    Barker HF; Ball J; Drew M; Hamilton MS; Franklin IM
    Leuk Lymphoma; 1992 Oct; 8(3):189-96. PubMed ID: 1490146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive expression of IL-6-LIKE cytokines in normal bone marrow: implications for pathophysiology of myeloma.
    Barton BE; Murphy TF
    Cytokine; 2000 Oct; 12(10):1537-45. PubMed ID: 11023670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment.
    Mitsiades CS; Mitsiades NS; Richardson PG; Munshi NC; Anderson KC
    J Cell Biochem; 2007 Jul; 101(4):950-68. PubMed ID: 17546631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44.
    Vacca A; Di Loreto M; Ribatti D; Di Stefano R; Gadaleta-Caldarola G; Iodice G; Caloro D; Dammacco F
    Am J Hematol; 1995 Sep; 50(1):9-14. PubMed ID: 7545353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
    Basile A; Moschetta M; Ditonno P; Ria R; Marech I; De Luisi A; Berardi S; Frassanito MA; Angelucci E; Derudas D; Specchia G; Curci P; Pavone V; Rossini B; Ribatti D; Bottazzi B; Mantovani A; Presta M; Dammacco F; Vacca A
    J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapeutic targets in multiple myeloma.
    Davies FE; Anderson KC
    Eur J Haematol; 2000 Jun; 64(6):359-67. PubMed ID: 10901589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of bone lesions in multiple myeloma and lymphoma.
    Roodman GD
    Cancer; 1997 Oct; 80(8 Suppl):1557-63. PubMed ID: 9362422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion.
    Parmo-Cabañas M; Bartolomé RA; Wright N; Hidalgo A; Drager AM; Teixidó J
    Exp Cell Res; 2004 Apr; 294(2):571-80. PubMed ID: 15023543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix protein Reelin promotes myeloma progression by facilitating tumor cell proliferation and glycolysis.
    Qin X; Lin L; Cao L; Zhang X; Song X; Hao J; Zhang Y; Wei R; Huang X; Lu J; Ge Q
    Sci Rep; 2017 Mar; 7():45305. PubMed ID: 28345605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Implication of bone marrow microenvironment in pathogenesis of multiple myeloma].
    Fišerová B; Kubiczková L; Sevčíková S; Hájek R
    Klin Onkol; 2012; 25(4):234-40. PubMed ID: 22920162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.